Published March 2022

This practice advisory reviews and explains the data supporting recommendations for medical management for reducing the risk of recurrent stroke or death in patients with symptomatic intracranial atherosclerotic arterial stenosis (s-ICAS). Antithrombotics, dyslipidemic agents, and lifestyle modifica

Published February 2014

This updated guideline reviews the evidence published since 1998 with regard to the detection of NVAF in patients with stroke and new therapies for the prevention of stroke in patients with NVAF. Reaffirmed on October 22, 2022. Endorsed by the World Stroke Organization.

Published June 2016

This practice advisory addresses the following question: For adult patients with poststroke disability, does etanercept administered by any route (compared with no etanercept or placebo) improve functional status? Reaffirmed on April 30, 2022.

Published April 2020

Reaffirmed on July 14, 2023. This practice advisory updates the AAN's 2016 practice advisory on closure of patent foramen ovale (PFO). The practice advisory concludes that, while the absolute risk reduction is not large, there is likely a clinically meaningful benefit for younger patients. Import